Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Large Numbers of Trial Results Go Unreported; WHO Says “Report Them”

May 8, 2015 8:39 am | by Cynthia Fox, Science Editor | Articles | Comments

The World Health Organization (WHO) announced what many feel is a strong, long-overdue statement condemning parties who do not report results of clinical trials in a timely way. By one account, more than 30 percent of industry and academic groups in the U.S. have not reported results of their clinical trials for 60 months, plus. The WHO outlined specific, and strict, solutions. Read more...


AbbVie Receives Breakthrough Designation for Cancer Drug

May 7, 2015 11:40 am | by Stephanie Guzowski, Editor | News | Comments

The U.S. Food and Drug Administration has granted breakthrough therapy designation for its leukemia drug, venetoclax, to speed up the regulatory review process. Read more...


Statin Drugs Can Delay Prostate Cancer Progression in Patients, Study Shows

May 7, 2015 11:25 am | by Dana-Farber Cancer Institute | News | Comments

​Men who went on cholesterol-lowering statin drugs when they began androgen deprivation therapy for prostate cancer had a longer time in which their disease was under control than did men who didn't take statins, a clinical trial led by Dana-Farber Cancer Institute investigators shows. Read more...


J&J Seeks Bioethics Advice on Compassionate Use of Drugs

May 7, 2015 10:27 am | by Lauren Neergaard, AP Medical Writer - Associated Press | News | Comments

Dying patients sometimes seek emergency access to experimental medicines, desperate for a last-chance treatment even if there's little proof it could help. Now drug giant Johnson & Johnson is taking an unusual step, turning to independent bioethicists for advice on when to say yes or no. Read more...


Existing Drug May Treat Deadliest Childhood Brain Tumor, Study Finds

May 7, 2015 10:22 am | by Erin Digitale, pediatrics science writer for Stanford University | News | Comments

A multicenter study has identified an FDA-approved medication that prolongs survival in mice with diffuse intrinsic pontine glioma, a brain tumor that now lacks chemotherapy treatments. Read more...


Advantage for Picture-Based Cigarette Pack Warnings Over Text Warnings

May 7, 2015 10:10 am | by University of North Carolina at Chapel Hill | News | Comments

Pictures illustrating the dangers of cigarette smoking were more effective at strengthening people’s intentions to quit smoking than text warnings, a University of North Carolina at Chapel Hill analysis of multiple research studies has found. Read more...


Tackling the Challenges of Antibody Development

May 7, 2015 9:30 am | by Tim Moran, director of life science research at BIOVIA | Articles | Comments

As organizations in the pharmaceutical and biopharmaceutical space shift their focus from small molecules to protein-based therapies, they can no longer rely on traditional research approaches. Read more...


UN: Lowest Number of New Weekly Ebola Cases in West Africa

May 7, 2015 8:42 am | by The Associated Press | News | Comments

The World Health Organization said the number of Ebola cases reported in Guinea and Sierra Leone last week dropped to 18, the lowest total this year. Read more...


New Malaria Vaccine Shows Promise in Field Trial

May 7, 2015 8:38 am | by University of Oxford | News | Comments

Following a trial in Kenya, the vaccine was found to be 67 percent effective against infection with Plasmodium falciparum, one of the parasites known to cause Malaria. Read more...


Study of Rare Syndrome Unlocks Secret of Human Aging

May 7, 2015 8:27 am | by Seth Augenstein, Digital Reporter | News | Comments

A group of scientists from China and the U.S. investigating a rare premature aging disease have found what they believe to be one of the underlying causes of normal human aging. What’s more, the new breakthrough could point toward methods of preventing and treating age-related problems, according to the paper, first published in the journal Science. Read more...


Alzheimer’s Disease Treatment Market Value Will Exceed $13B

May 7, 2015 8:26 am | by Kyle S. Nicholson, PharmD, GlobalData Neurology Analyst | News | Comments

The global market for Alzheimer’s Disease (AD) treatment will more than double in value from $4.9 billion in 2013 to reach an estimated $13.3 billion by 2023, representing a Compound Annual Growth Rate (CAGR) of 10.50 percent, according to research and consulting firm GlobalData. Read more...


Kymab Raises $90M to Support Monoclonal Antibody Pipeline

May 7, 2015 8:26 am | by Ryan Bushey, Associate Editor | Articles | Comments

The Bill and Melinda Gates Foundation was one of the primary investors this round. Read more...


Epilepsy Drug Could Help Treat Alzheimer's Disease

May 7, 2015 8:25 am | by University of British Columbia | News | Comments

While the drug appears effective, the researchers are unclear how it works to reverse memory loss. Read more...


AACR and Social Media Buzz

May 6, 2015 1:40 pm | by Stephanie Guzowski, Editor | News | Comments

More and more, researchers are turning to social media to post news and scientific insights, and to discuss science among peers as well as share findings with the public. AACR reported on the annual meeting's overall social media highlights. Read more...


Stem Cells Safe to Treat Post-Stroke Brains, Study Says

May 6, 2015 11:17 am | by Seth Augenstein, Digital Reporter | Articles | Comments

​Stem cells can be safely infused to the brain through the carotid artery after a stroke, according to new research presented by a group of doctors and researchers. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.